Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study.
Dragoni G, Castiglione F, Bezzio C, Pugliese D, Spagnuolo R, Viola A, Cocomazzi F, Aratari A, Savarino EV, Balestrieri P, Onali S, Viganò C, Ribaldone DG, Innocenti T, Testa A, Saibeni S, Privitera G, Milla M, Armuzzi A, Fantini MC, Fiorino G. Dragoni G, et al. Among authors: privitera g. United European Gastroenterol J. 2023 Apr;11(3):271-281. doi: 10.1002/ueg2.12367. Epub 2023 Mar 21. United European Gastroenterol J. 2023. PMID: 36942657 Free PMC article.
Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease.
Pugliese D, Privitera G, Pizzolante F, Gasbarrini A, Guidi L, Armuzzi A. Pugliese D, et al. Among authors: privitera g. Minerva Gastroenterol Dietol. 2019 Dec;65(4):280-290. doi: 10.23736/S1121-421X.19.02625-4. Epub 2019 Oct 24. Minerva Gastroenterol Dietol. 2019. PMID: 31646853 Review.
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease.
Guidi L, Pugliese D, Panici Tonucci T, Bertani L, Costa F, Privitera G, Tolusso B, Di Mario C, Albano E, Tapete G, Gremese E, Papa A, Gasbarrini A, Rapaccini GL, Armuzzi A. Guidi L, et al. Among authors: privitera g. United European Gastroenterol J. 2019 Nov;7(9):1189-1197. doi: 10.1177/2050640619873784. Epub 2019 Sep 3. United European Gastroenterol J. 2019. PMID: 31700632 Free PMC article.
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A. Scaldaferri F, et al. Among authors: privitera g. United European Gastroenterol J. 2020 Aug;8(7):775-781. doi: 10.1177/2050640620929133. Epub 2020 May 21. United European Gastroenterol J. 2020. PMID: 32438878 Free PMC article.
Assessment of neurological manifestations in hospitalized patients with COVID-19.
Luigetti M, Iorio R, Bentivoglio AR, Tricoli L, Riso V, Marotta J, Piano C, Primiano G, Zileri Del Verme L, Lo Monaco MR, Calabresi P; GEMELLI AGAINST COVID-19 group. Luigetti M, et al. Eur J Neurol. 2020 Nov;27(11):2322-2328. doi: 10.1111/ene.14444. Epub 2020 Aug 24. Eur J Neurol. 2020. PMID: 32681611 Free PMC article.
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, Pugliese D, Neri M, Cammarota G, Ringel Y, Costamagna G, Gasbarrini A, Boskoski I, Armuzzi A. Scaldaferri F, et al. Among authors: privitera g. Inflamm Bowel Dis. 2020 Aug 20;26(9):1306-1314. doi: 10.1093/ibd/izaa181. Inflamm Bowel Dis. 2020. PMID: 32720978 Free PMC article. Review.
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients.
Pugliese D, Guidi L, Privitera G, Bertani L, Tolusso B, Papparella LG, Maltinti S, Di Mario C, Onali S, Ceccarelli L, Rapaccini GL, Scaldaferri F, Gremese E, Gasbarrini A, Costa F, Armuzzi A. Pugliese D, et al. Among authors: privitera g. Expert Opin Biol Ther. 2021 Jan;21(1):97-104. doi: 10.1080/14712598.2020.1839045. Epub 2020 Oct 31. Expert Opin Biol Ther. 2021. PMID: 33074723
333 results